Please use this identifier to cite or link to this item:
|Title:||α-Galactosylceramide Analogs with Weak Agonist Activity for Human iNKT Cells Define New Candidate Anti-Inflammatory Agents||Authors:||Bricard, G.
|Issue Date:||2010||Citation:||Bricard, G., Venkataswamy, M.M., Yu, K.O.A., Im, J.S., Ndonye, R.M., Howell, A.R., Veerapen, N., Illarionov, P.A., Besra, G.S., Li, Q., Porcelli, S.A., Chang Young-Tae (2010). α-Galactosylceramide Analogs with Weak Agonist Activity for Human iNKT Cells Define New Candidate Anti-Inflammatory Agents. PLoS ONE 5 (12) : 1-16. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0014374||Abstract:||CD1d-restricted natural killer T cells with invariant T cell receptor a chains (iNKT cells) are a unique lymphocyte subset that responds to recognition of specific lipid and glycolipid antigens. They are conserved between mice and humans and exert various immunoregulatory functions through their rapid secretion of a variety of cytokines and secondary activation of dendritic cells, B cells and NK cells. In the current study, we analyzed the range of functional activation states of human iNKT cells using a library of novel analogs of α-galactosylceramide (αGalCer), the prototypical iNKT cell antigen. Measurement of cytokines secreted by human iNKT cell clones over a wide range of glycolipid concentrations revealed that iNKT cell ligands could be classified into functional groups, correlating with weak versus strong agonistic activity. The findings established a hierarchy for induction of different cytokines, with thresholds for secretion being consistently lowest for IL-13, higher for interferon-γ (IFNc), and even higher for IL-4. These findings suggested that human iNKT cells can be intrinsically polarized to selective production of IL-13 by maintaining a low level of activation using weak agonists, whereas selective polarization to IL-4 production cannot be achieved through modulating the strength of the activating ligand. In addition, using a newly designed in vitro system to assess the ability of human iNKT cells to transactivate NK cells, we found that robust secondary induction of interferon-γ secretion by NK cells was associated with strong but not weak agonist ligands of iNKT cells. These results indicate that polarization of human iNKT cell responses to Th2-like or anti-inflammatory effects may best be achieved through selective induction of IL-13 and suggest potential discrepancies with findings from mouse models that may be important in designing iNKT cell-based therapies in humans. © 2010 Bricard et al.||Source Title:||PLoS ONE||URI:||http://scholarbank.nus.edu.sg/handle/10635/95429||ISSN:||19326203||DOI:||10.1371/journal.pone.0014374|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
|2010-α-Galactosylceramide_analogs_weak_agonist_activity-pub.pdf||1.23 MB||Adobe PDF|
checked on Jan 13, 2021
WEB OF SCIENCETM
checked on Jan 4, 2021
checked on Jan 9, 2021
checked on Jan 9, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.